Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1200 of 1294 entries
View as:

Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT03638778 Org: User:
Start: 08/17/18 End: 12/05/18 Due: 12/05/19

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01620424 Org: User:
Start: 02/28/01 End: 04/30/01 Due: 04/30/02

Comparison of Glycemic Control Achieved With 2 Different Needles

Phase: N/A Priority: Normal
NCT ID: NCT00572052 Org: User:
Start: 12/31/02 End: 10/31/03 Due: 10/31/04

Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®

Phase: N/A Priority: Normal
NCT ID: NCT01984372 Org: User:
Start: 11/06/13 End: 04/30/19 Due: 04/30/20

Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00709475 Org: User:
Start: 05/31/08 End: 10/31/09 Due: 10/31/10

A Research Study of the Effect of Food on Etavopivat in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06433661 Org: User:
Start: 05/28/24 End: 07/08/24 Due: 07/08/25

Special Survey for Patients With Type 1 or Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01538589 Org: User:
Start: 12/31/03 End: 10/31/09 Due: 10/31/10

Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00593255 Org: User:
Start: 07/31/04 End: 04/30/05 Due: 04/30/06

Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00267683 Org: User:
Start: 12/31/05 End: 04/30/06 Due: 04/30/07

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Phase: N/A Priority: Normal
NCT ID: NCT05259033 Org: User:
Start: 04/11/22 End: 01/16/24 Due: 01/16/25

A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Saudi Arabia

Phase: N/A Priority: Normal
NCT ID: NCT03785522 Org: User:
Start: 12/23/18 End: 11/30/20 Due: 11/30/21

Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

Phase: N/A Priority: Normal
NCT ID: NCT06122961 Org: User:
Start: 11/23/23 End: 04/30/25 Due: 04/30/26

Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658

Phase: N/A Priority: Normal
NCT ID: NCT01529944 Org: User:
Start: 09/30/08 End: 10/31/08 Due: 10/31/09

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT01562834 Org: User:
Start: 10/21/98 End: 12/01/02 Due: 12/01/03

Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT00834262 Org: User:
Start: 04/30/09 End: 02/28/10 Due: 02/28/11

Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01392547 Org: User:
Start: 07/31/11 End: 08/31/12 Due: 08/31/13

A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02911870 Org: User:
Start: 09/23/16 End: 05/11/17 Due: 05/11/18

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01272973 Org: User:
Start: 01/31/11 End: 07/31/11 Due: 07/31/12

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01885208 Org: User:
Start: 12/02/13 End: 07/13/15 Due: 07/13/16

Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725

Phase: N/A Priority: Normal
NCT ID: NCT00978380 Org: User:
Start: 09/21/09 End: 10/20/15 Due: 10/20/16

Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®

Phase: N/A Priority: Normal
NCT ID: NCT00658099 Org: User:
Start: 11/30/07 End: 06/30/08 Due: 06/30/09

A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03196284 Org: User:
Start: 08/10/17 End: 01/31/20 Due: 01/31/21

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT03528551 Org: User:
Start: 04/30/18 End: 12/03/20 Due: 12/03/21

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02933853 Org: User:
Start: 10/14/16 End: 12/21/17 Due: 12/21/18

A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together

Phase: N/A Priority: Normal
NCT ID: NCT05435677 Org: User:
Start: 06/22/22 End: 04/25/23 Due: 04/25/24